Dr. Berger on Benefits of New Screening Test for CRC

Barry M. Berger, MD, FACP
Published: Tuesday, Oct 11, 2016


Barry M. Berger, MD, FACP, chief medical officer, Exact Sciences, discusses Cologuard screening test for colorectal cancer (CRC).
 
The test was designed to address patient preferences and does not require a preparation, time off work, changes in diet or medication, and can be administered by the patient in his or her own home.
 
After the patient receives the kit and administers the test it can be mailed via UPS back to the lab that requested it, says Berger. The physician and the patient can also access a 24-hour call line if they need any assistance.
 
The test has resulted in an increase in CRC screening, says Beger. Sixty percent of the patients that use this test have never been screened before.
 

Barry M. Berger, MD, FACP, chief medical officer, Exact Sciences, discusses Cologuard screening test for colorectal cancer (CRC).
 
The test was designed to address patient preferences and does not require a preparation, time off work, changes in diet or medication, and can be administered by the patient in his or her own home.
 
After the patient receives the kit and administers the test it can be mailed via UPS back to the lab that requested it, says Berger. The physician and the patient can also access a 24-hour call line if they need any assistance.
 
The test has resulted in an increase in CRC screening, says Beger. Sixty percent of the patients that use this test have never been screened before.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x